Validation of SAPS3 admission score and its customization for use in Korean intensive care unit patients: A prospective multicentre study by 고신옥
ORIGINAL ARTICLE
Validation of SAPS3 admission score and its customization for
use in Korean intensive care unit patients: A prospective
multicentre study
SO YEON LIM,1 SHIN OK KOH,2 KYEONGMAN JEON,1,3 SUNGWON NA,2 CHAE-MAN LIM,4 WON-IL CHOI,5
YOUNG-JOO LEE,6 SEOK CHAN KIM,7 GYU RAK CHON,8 JE HYEONG KIM,9 JAE YEOL KIM,10 JAEMIN LIM,11
CHIN KOOK RHEE,7 SUNGHOON PARK,12 HO CHEOL KIM,13 JIN HWA LEE,14 JI HYUN LEE,15 JISOOK PARK,16
YOUNSUCK KOH,4 GEE YOUNG SUH,1,3 The Validation of Simplified acute physiology score 3
in Korean Intensive care unit (VSKI) study group* AND THE Korean Study group on
Respiratory Failure (KOSREF)
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Seoul, 2Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain
Research Institute, Yonsei University College of Medicine, Seoul, 3Department of Critical Care Medicine, Samsung Medical
Center, Sungkyunkwan University School of Medicine, Seoul, 4Division of Pulmonary and Critical Care Medicine,
Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 5Division of Pulmonary and
Critical Care Medicine, Department of Medicine, Dongsan Hospital, Keimyung University, Daegu, 6Department of
Anesthesiology, Aju University College of Medicine, Suwon, 7Division of Pulmonary and Critical Care Medicine, Department
of Medicine, Seoul St. Mary’s Hospital, Catholic University of Korea, Seoul, 8Division of Pulmonary and Critical Care
Medicine, Department of Medicine, Chungju Hospital, School of Medicine of Konkuk University, Chungju, 9Division of
Pulmonary, Sleep and Critical Care Medicine, Department of Medicine, Korea University Ansan Hospital, Ansan, 10Division
of Pulmonary and Critical Care Medicine, Department of Medicine, Chung-Ang University College of Medicine, Seoul,
11Division of Pulmonary and Critical Care Medicine, Department of Medicine, Gangneung Asan Hospital, University of Ulsan
Medical College of Medicine, Gangneung, 12Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University
Sacred Heart Hospital, Anyang, 13Division of Pulmonary and Critical Care Medicine, Department of Medicine, College of
Medicine, Gyeongsang Institute of Health Sciences, Gyeongsang National University, Jinju, 14Division of Pulmonary and
Critical Care Medicine, Department of Medicine, Ewha Womans University School of Medicine, Seoul, 15Division of
Pulmonary and Critical Care Medicine, Department of Medicine, Bundang CHA hospital CHA university, Seongnam, and
16Department of Multimedia, Seoul Women’s University, Seoul, Korea
ABSTRACT
Background and objective: To externally validate the
simplified acute physiology score 3 (SAPS3) and to cus-
tomize it for use in Korean intensive care unit (ICU)
patients.
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SUMMARY AT A GLANCE
We investigated to validate the simplified acute
physiology score 3 (SAPS3) and to customize it
in Korean ICUs. General and Australasia SAPS3
showed poor calibration, but the prognostic power
was improved by customization. Prediction
models should be customized before being used to
predict mortality in different regions.
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Methods: This is a prospective multicentre cohort
study involving 22 ICUs from 15 centres throughout
Korea. The study population comprised patients who
were consecutively admitted to participating ICUs
from 1 July 2010 to 31 January 2011.
Results: A total of 4617 patients were enrolled. ICU
mortalitywas 14.3%,andhospitalmortalitywas 20.6%.
The patients were randomly assigned into one of two
cohorts: a development (n = 2309) or validation
(n = 2308) cohort. In the development cohort, the
general SAPS3 had good discrimination (area under
the receiver operating characteristics curve = 0.829),
but poor calibration (Hosmer–Lemeshow goodness-of-
fit testH = 123.06,P < 0.001,C = 118.45,P < 0.001).The
Australasia SAPS3 did not improve calibration
(H = 73.53, P < 0.001, C = 70.52, P < 0.001). Customiza-
tion was achieved by altering the logit of the original
SAPS3 equation. The new equation for Korean ICU
patients was validated in the validation cohort, and
demonstrated both good discrimination (area under
the receiver operating characteristics curve = 0.835)
and good calibration (H = 4.61, P = 0.799, C = 5.67,
P = 0.684).
Conclusions: General and regional Australasia SAPS3
admission scores showed poor calibration for use in
Korean ICU patients, but the prognostic power of the
SAPS3 was significantly improved by customization.
Prediction models should be customized before being
used to predict mortality in different regions of the
world.
Key words: calibration, discrimination, intensive care unit,
severity of illness.
Abbreviations: AUS-SAPS3, Australasia SAPS3; GOF, good-
ness of fit; ICU, intensive care unit; SAPS3, simplified acute
physiology score 3; SMR, standardized mortality ratio.
INTRODUCTION
Severity scoring systems are used to predict and
compare outcomes to help guide the allocation of
limited resources and to evaluate the process of care.1
However, there is large variability in the performance
of general severity scoring systems,2,3 which is mostly
attributable to differences in patient case-mix or
changing medical practice over time.
Recently, the simplified acute physiology score 3
(SAPS3) was developed through aworldwide prospec-
tive study to predict hospital mortality in critically ill
patients.4 The SAPS3 admission score was designed to
be used on multiple levels; thus, the system encom-
passed not only a general equation but also regional
equations customized for use in specific geographical
areas.4 However, external validation studies of the
SAPS3 have reported mixed results.5–10 Although there
are some reports of validation of the SAPS3 in Asian
cohorts,5,6 the general and Australasia SAPS3 (AUS-
SAPS3) equations have never been validated in a
large, prospective multicentre cohort in Asia.
Therefore, the aim of this study was to evaluate the
prognostic performance of the SAPS3 in a large pro-
spective cohort in Korea, and to assess the need for
region-specific or country-specific customization of
the SAPS3.
METHODS
This is a prospective multicentre cohort study. The
validation of the SAPS3 in Korean intensive care units
(ICUs) (VSKI) was conducted by the Korean Study
Group on Respiratory Failure between 1 July 2010 and
31 January 2011. The study included patients from 22
participating ICUs (medical = 14, surgical = 6, multi-
disciplinary = 2) in 15 tertiary or university-affiliated
hospitals. The study was approved by each hospital’s
institutional review board, and the requirement for
informed consent was waived due to the non-
interventional nature of the study.
Patients
All patients admitted to the 22 ICUs during the study
period were eligible for this study. We excluded
patients if they were younger than 17 years old or if
the primary outcome of hospital mortality was uncer-
tain. Patients whowere transferred fromother partici-
pating ICUs were also excluded. For patients with two
or more admissions to the ICU during the same hos-
pital stay, only the data from the first admission were
used.
Data collection
Patient data were collected using a web-based data-
base. The definitions of variables used in the original
SAPS3 model were used for this study.4 We used the
most abnormal set of data from the period 1 h prior to
or after ICU admission to calculate the SAPS3. Pre-
dicted hospital mortalities were calculated using the
general SAPS3 and the customized AUS-SAPS3
equations as follows: Logit = -32.6659 + ln (SAPS3 +
20.5958) ¥ 7.3068 for general SAPS3, Logit =
-22.5717 + ln (SAPS3 + 1) ¥ 5.3163 for AUS-SAPS3 and
the probability of death = elogit/(1 + elogit).4
The study population was randomly divided into
development or validation cohort. The performances
of the general SAPS3 and the Asian-specific SAPS3
(AUS-SAPS3) were validated externally in the devel-
opment cohort. After confirming poor performances
of two scores, a new equation customized for use in
Korean ICU patients was derived. Subsequently, the
newly customized SAPS3 for Korea (K-SAPS3) was
validated in the validation cohort using the AUS-
SAPS3 for comparison.
Data quality
For data quality, 5% of the study participants were
randomly selected and had their data recollected.
Their original SAPS3 data and recalculated SAPS3
data were compared to assess the reliability of data
collection process. The kappa value was 0.83
(P < 0.001).
Method of model customization
First-level customization was performed using logis-
tic regression analysis by computing new logistic
coefficient while maintaining the same variables with
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the same weights as in the original model. Hospital
mortality was the dependent outcome variable.
Statistical analysis
For statistical analysis, PASW 17.0 (SPSS Inc., Chicago,
IL, USA) and STATA 11.0 (StataCorp LP, Texas, USA)
were used. Data are shown asmedians and interquar-
tile ranges, or numbers with percentages. A two-
tailed P-value of <0.05 was considered statistically
significant.
Generally, evaluation of performance of scoring
systemusually includes assessment of calibration and
discrimination. Calibration is defined as the agree-
ment between individual probabilities and actual
outcomes.11 Hosmer–Lemeshow goodness-of-fit
(GOF) H statistic and GOF C statistics were used to
evaluate calibration.11 To assess GOF, patients were
divided into 10 groups either by expected mortality
intervals (H statistic) or 10 equal number groups (C
statistic), and the expected number of death as pre-
dicted by SAPS3 was compared with the observed
number of death in each group. The number of
expected outcomes was calculated by multiplying the
mean of predicted probabilities and the number of
patients in each group. A P > 0.05 was accepted as
indicating good fit of the model.
The standardized mortality ratio (SMR) was calcu-
lated by dividing the number of observed deaths by
the number of expected deaths in each cohort. To test
for statistical significance, we calculated 95% confi-
dence intervals according to themethod described by
Hosmer and Lemeshow.11 In a perfect model, they
should not be different from one.
Discrimination is the power to distinguish between
survivors and non-survivors, and was assessed by cal-
culating the area under the receiver operating charac-
teristic curve, as described by Hanley and McNeil.12
Generally, an area under the receiver operating
characteristics curve greater than 0.9 is defined as
indicating excellent discrimination, 0.8  area under
the receiver operating characteristics curve < 0.9
good discrimination and 0.7  area under the
receiver operating characteristics curve < 0.8 modest
discrimination.12,13
RESULTS
Baseline characteristics of patients
A total of 4617 patients were enrolled during the study
period. To customize and validate the K-SAPS3, the
study population was randomly split into a develop-
ment cohort (n = 2309) or a validation cohort
(n = 2308).
The clinical characteristics and outcomes of the
patients are described in Table 1.Males accounted for
64.7% (1493/2309) of the development cohort, and
themedian age overall in the groupwas 62 (interquar-
tile range 49–72). Males accounted for 59.5% (1373/
2308) of the validation cohort, and the median age
was 62 (interquartile range 49–72). Patients weremost
frequently transferred to the ICU from the general
medicine ward, and the second most common loca-
tion prior to ICU transfer was the emergency room.
Hypertension, solid cancer and diabetes mellitus
were the most frequent comorbidities. The need for
clinical observation was the most frequent reason for
ICU admission. Respiratory and cardiovascular dis-
eases were the most frequent organ-specific indica-
tions for ICU admission. The prevalence of
nosocomial infection at the time of ICU admission
was 8.1% in the development cohort and 6.4% in the
validation cohort (P < 0.001). The prevalence of
community-acquired infection was 21.4% in the
development cohort and 14% in the validation cohort
(P < 0.001). The median sequential organ failure
assessment score was 5 (interquartile range 2–9) in
the development cohort and 6 (interquartile range
3–10) in the validation cohort (P < 0.001). ICUmortal-
ity was 12.9% in the development cohort and 15.6% in
the validation cohort (P = 0.01), with hospitalmortali-
ties of 20.1% and 21.1%, respectively (P = 0.40).
Performance assessment of general SAPS3 and
AUS-SAPS3 in the development cohort
The calibration and discrimination of the general
SAPS3 and the AUS-SAPS3 are reported in Table 2.
Overall, a significant discrepancy was observed
between the observed and expected mortalities
across all strata when the general SAPS3 was used
(Hosmer–Lemeshow GOF H of 123.06 (P < 0.001) and
a Hosmer–Lemeshow GOF C of 118.45 (P < 0.001))
(Fig. 1). The general SAPS3 generated an SMR of 0.72
(95% confidence interval: 0.65–0.78). The overall dis-
criminatory power of the general SAPS3, as measured
by the area under the receiver operating characteris-
tics curve, was 0.829. The AUS-SAPS3 also showed
poor calibration (H = 73.53, P < 0.0001, C = 70.52,
P < 0.001) (Fig. 2). The AUS-SAPS3 generated an SMR
of 0.78 (95% confidence interval: 0.71–0.85). The dis-
criminatory power of the AUS-SAPS3 was 0.829.
Derivation of new SAPS3 equation for Korean
intensive care unit patients
The customized equation for Korea was derived as:
Logit SAPS= − + +( )×35 1752 3 20 5958 7 7379. ln . .
Performance assessment of AUS-SAPS3 and
K-SAPS3 in the validation cohort
The calibration and discrimination of the AUS-SAPS3
and K-SAPS3 in the validation cohort are reported in
Table 3. The AUS-SAPS3 showed poor calibration,
with a Hosmer–Lemeshow GOF H of 72.71 (P < 0.001)
and a Hosmer–Lemeshow GOF C of 68.06 (P < 0.001).
The SMR predicted by the AUS-SAPS3model was 0.77
(95% confidence interval: 0.70–0.84). By comparison,
the K-SAPS3 showed good calibration (H = 4.61,
P = 0.799, C = 5.67, P = 0.684) (Fig 3). The SMR pre-
dicted by the K-SAPS3 was 0.99 (95% confidence
interval: 0.90–1.08). The discriminatory power of the
K-SAPS3 was 0.835.
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Table 1 Baseline characteristics and outcome data of the two cohorts
Development cohort Validation cohort
PN or Median % or IQR N or Median % or IQR
Number of patients 2309 2308 —
Male 1493 64.7 1373 59.5 0.25
Age (years) 62 49–72 62 49–72 0.94
SOFA 5 2–9 6 3–10 <0.001
Intra-hospital location before ICU admission <0.001
Emergency room 1066 46.2 989 42.9
General ward 1163 50.4 1256 54.4
Other ICU 53 2.3 20 0.9
Others 27 1.2 43 1.9
Comorbidity (overlapped) —
Hypertension 842 36.5 714 30.9
CHF 146 6.3 34 1.5
Stroke 178 7.8 79 3.4
COPD 79 3.4 56 2.4
DM 526 22.8 450 19.5
CRF 208 9.0 131 5.7
Haematological cancer 103 4.5 71 3.1
Solid cancer 848 36.7 669 29.0
Unplanned ICU admission 1134 49.1 1001 43.4 <0.001
Reason for ICU admission —
Observational† 1076 46.6 1064 46.1
Cardiovascular 339 14.7 251 10.9
Digestive 86 3.7 142 6.2
Haematological cancer 8 0.4 10 0.4
Hepatic failure 46 2.0 115 5.0
Metabolic 57 2.5 33 1.4
Neurological 140 6.1 101 4.4
Renal 54 2.3 24 1.0
Respiratory 370 16.0 374 16.2
Others 133 5.8 194 8.4
Surgical status <0.001
No surgery 1390 60.2 1163 50.4
Scheduled surgery 760 32.9 936 40.6
Emergent surgery 159 6.9 209 9.1
Acute infection at ICU admission 683 29.6 470 20.4 <0.001
Hospital-acquired 188 8.1 147 6.4
Community-acquired 495 21.4 323 14.0
ICU length of stay 3 2–7 4 2–10 <0.001
Hospital length of stay 23 21–25 21 12–40 <0.001
ICU mortality 299 12.9 359 15.6 0.01
Hospital mortality 463 20.1 486 21.1 0.40
† Preparation for routine post-surgery care including simple weaning from ventilator after surgery.
CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; DM, diabetes mellitus; ICU,
intensive care unit; IQR, interquartile range; SOFA, sequential organ failure assessment.
Table 2 Discrimination and calibration of general SAPS3 and AUS-SAPS3 in the development cohort
Prediction model Score Predicted mortality GOF H-test P GOF C-test P SMR 95% CI aROC
SAPS3 52 (41–64) 20.5 (7.2–44) 123.06 <0.001 118.45 <0.001 0.72 0.65–0.78 0.829
AUS-SAP 3 — 18.8 (6.3–40.6) 73.53 <0.001 70.52 <0.001 0.78 0.71–0.85 0.829
aROC, area under the receiving operator characteristics curve; AUS-SAPS, Australasia simplified acute physiology score; CI,
confidence intervals; GOF, goodness of fit; SAPS3, simplified acute physiology score 3; SMR, standardized mortality ratio.
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DISCUSSION
This study demonstrates that the general and regional
AUS-SAPS3 had good discrimination but poor cali-
bration in a region-specific cohort from an Asian
country. Calibration was improved after customiza-
tion of the SAPS3 equation with data from the devel-
opment cohort, and this newly derived equation for
Korea showed good discrimination and good calibra-
tion in a separate validation cohort.
Figure 1 Calibration curves of the general
simplified acute physiology score 3
(SAPS3) in development cohort. ,
patients (right); , expected (left);
, observed (left). Predicted risk of
hospital mortality, observed hospital mor-
tality and the corresponding number of
patients are shown. In the upper panel,
x-axis represents patients divided into 10
groups according to predicted mortality
based on general SAPS3 model. In the
lower panel, x-axis represents predicted
rate of mortality by approximate decile of
patients. In both curves, significant differ-
ences between curves representing pre-
dicted and observed mortalities are
observed (P < 0.001). Columns: number of
patients; line with open circles: mean pre-
dicted mortality; line with closed circles:
mean observed mortality.
Figure 2 Calibration curves of the Aus-
tralasia simplified acute physiology score
3 (SAPS3) in development cohort. ,
patients (right); , expected (left);
, observed (left). Predicted risk of
hospital mortality, observed hospital mor-
tality and the corresponding number of
patients are shown. In the upper panel,
x-axis represents patients divided into 10
groups according to predicted mortality
based on Australasia SAPS3 model. In the
lower panel, x-axis represents predicted
rate of mortality by approximate decile of
patients. In both curves, significant differ-
ences between curves representing pre-
dicted and observed mortalities are
observed (P < 0.001). Columns: number of
patients; line with open circles: mean pre-
dicted mortality; line with closed circles:
mean observed mortality.
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To our knowledge, this current study is the first
study that aimed to validate the general SAPS3 and
the AUS-SAPS3 equations by using a multicentre
design in critically ill Asian patients. The only other
prospective validation study of SAPS3 in Asian popu-
lation was a smaller single-centre study performed in
Thailand.5 In that study, both general SAPS3 and AUS-
SAPS3 had excellent discrimination but poor calibra-
tion in the medical ICU. After customization of the
SAPS3, the calibration of SAPS3 was improved. There
are important differences between this current study
and the Thai study. This study was multicentre (15 vs
1), had more patients (4617 vs 1873) and included
more diverse patients (both medical and surgical vs
just medical). In the current study, the general and
AUS-SAPS3 demonstrated good discrimination but
poor calibration. Although the regional equations of
SAPS3were developed for use in specific geographical
area, the AUS-SAPS3 did not perform well in this
cohort of Korean patients. This is not surprising when
we consider how AUS-SAPS3 equation was devel-
oped. The AUS-SAPS3 equation was derived from
data collected from 1756 patients from Australia
(n = 651), India (n = 532) and Hong Kong (n = 573).4,14
There are likely to be vast differences in the character-
istics of patients from these three areas stemming
from significant variability in the genetic make-up,
cultural and social structures, the availability of
resources, and the delivery of critical care, as reflected
in the wide range of reported SMR in the original
SAPS3 study (0.7–1.4).4,14 There is no clear advantage
to grouping the data from these three countries
simply because they are roughly within the same geo-
graphical area. It is interesting that Hong Kong, which
is the most geographically and genetically similar to
Korea, had an SMR of 0.7, which is similar to the value
found in this study.4,14We believe that country-specific
customization of the general or regional SAPS3 equa-
tion is needed to obtain accurate prediction.
Both the general SAPS3 and AUS-SAPS3 equations
showed poor calibration, overestimating mortality
rates (low SMR) across all strata. A low SMR has also
been reported in other developed countries, such as
Belgium,8 Italy,10 and Thailand.5 Although variations
in case-mix, genetic predispositions15,16 and cultural
differences17 may explain some of this differences,
another reasonmay be the change in practice of criti-
cal care since the completion of the SAPS3 project.
Table 3 Discrimination and calibration of the AUS-SAPS3 and K-SAPS3 in the validation cohort
Prediction model Predicted mortality GOF H-test P GOF C-test P SMR 95% CI aROC
AUS-SAPS3 20.3 (7.9–42.6) 72.71 <0.001 68.06 <0.001 0.77 0.70–0.84 0.835
K-SAPS3 12.9 (4.6–32.2) 4.61 0.799 5.67 0.684 0.99 0.90–1.08 0.835
aROC, area under the receiver operating characteristics curve; AUS-SAPS, Australasia simplified acute physiology score; CI,
confidence intervals; GOF, goodness of fit; K-SAPS3, Korean simplified acute physiology score 3; SMR, standardized mortality ratio.
Figure 3 Calibration curves of the Korean
simplified acute physiology score 3
(SAPS3) in validation cohort. ,
patients (right); , expected (left);
, observed (left). Predicted risk of
hospital mortality, observed hospital mor-
tality and the corresponding number of
patients are shown. In the upper panel,
x-axis represents patients divided into 10
groups according to predicted mortality
based on Korean SAPS3 model. In the
lower panel, x-axis represents predicted
rate of mortality by approximate decile of
patients. In both curves, curves represent-
ing predicted and observed mortalities are
almost overlap showing good calibration
(P > 0.05). Columns: number of patients;
line with open circles: mean predicted
mortality; line with closed circles: mean
observed mortality.
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Effective treatment strategies, such as low tidal
volume ventilation in acute respiratory distress syn-
drome18 and early goal-directed therapy in severe
sepsis and septic shock19 whichwere just beginning to
become popular in 2002 when SAPS3 was developed,
have become standard of care. These and other inter-
ventions that have been implemented since 2002
surely would improve the outcome of patients, thus
decreasing the SMR.
There are statistically significant differences in
many of the baseline characteristics between devel-
opment and validation cohort. Since we used a robust
method in randomly allocating patients into two
groups, these differences are not due to bias but due
to randomness of the selection process. However,
these differences do not compromise the validation
process because, if anything, the differences in the
two groups would have adversely affected calibration.
One limitation of this study is that first-level cus-
tomization was used to customize SAPS3 to Korean
population.20 Although some suggest that customiz-
ing individual coefficients is more effective than cus-
tomizing the logit of the original equation, first-level
customization is a simple and practical method to
improve the calibration of severity scores. Another is
that all the participating centres were large university-
affiliated tertiary hospitals. Thus, our model may not
be accurate in patients admitted to smaller hospitals
with different models of delivery of critical care.
In conclusion, general and regional AUS-SAPS3
admission scores showed poor calibration in Korean
ICU patients, but the prognostic power of the SAPS3
model was significantly improved after country-
specific customization. Prediction models should be
customized before routine application to more accu-
rately predictmortality rates in different regions of the
world.
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